Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival

2012 ◽  
Vol 12 (5) ◽  
pp. 313-321 ◽  
Author(s):  
William J. Gradishar ◽  
Dimitry Krasnojon ◽  
Sergey Cheporov ◽  
Anatoly N. Makhson ◽  
Georgiy M. Manikhas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Overall Survival ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Final Analysis ◽  
First Line ◽  
Line Chemotherapy

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

2006 ◽  
Vol 6 (6) ◽  
pp. 505-510 ◽  
Author(s):  
Joyce A. O'Shaughnessy ◽  
Robert Pluenneke ◽  
Jack Sternberg ◽  
Pankaj Khandelwal ◽  
Des Ilegbodu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
Weekly Docetaxel ◽  
Locally Recurrent ◽  
Line Chemotherapy

A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932

Oncology ◽  
2005 ◽  
Vol 69 (2) ◽  
pp. 117-121 ◽  
Author(s):  
Edith A. Perez ◽  
Vera J. Suman ◽  
Tom R. Fitch ◽  
James A. Mailliard ◽  
James N. Ingle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document